Shell Decides Against Buying BP Amid Strategic Concerns
Shell leadership rejected an internal plan to buy BP in 2025, choosing shareholder returns over a complex mega-merger despite BP’s earlier struggles.
Markets move fast. You should move faster. Be the first to know when deals break, stocks move, or biotech headlines hit. Sign up to get breaking news alerts the moment they happen.
Shell leadership rejected an internal plan to buy BP in 2025, choosing shareholder returns over a complex mega-merger despite BP’s earlier struggles.
Rezolve Ai shares surge over 30% after management raises 2025 ARR guidance by 33%, signaling strong growth momentum.
Craig-Hallum starts coverage of Jumia with a Buy rating, highlighting growth potential in African e-commerce and long-term upside of $125-$250 per share.
BofA raises Estee Lauder price target to $130 and adds it to its top “US 1 list,” citing strong growth potential and the Beauty Reimagined plan.
Wells Fargo adjusts ratings and price targets for Capri, Gap, and Victoria’s Secret, highlighting sector trends and optimism for 2026.
Jefferies launched coverage on IonQ, Rigetti, and D-Wave, outlining ratings, price targets, and key opportunities and risks in quantum computing.